Trial site
Yale University, Yale Cancer Center
- 13running trials
- 7closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer4 trials
- Head and neck cancer4 trials
- Lung cancer4 trials
- Metastatic breast cancer4 trials
- Ovarian cancer4 trials
- Prostate cancer4 trials
- Triple-negative breast cancer3 trials
- Cervical cancer2 trials
- Gastric and oesophageal cancer2 trials
- Kidney cancer2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- and 5 more
- Phase
- Phase 28 trials
- Phase 1/25 trials
- Phase 35 trials
- Phase 12 trials
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed4 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- BeOne Medicines2 trials
- Michael B. Atkins, MD2 trials
- 858 Therapeutics, Inc.1 trial
- Adlai Nortye Biopharma Co., Ltd.1 trial
- Alentis Therapeutics AG1 trial
- and 14 more
Running trials
Recruiting
Recruiting
Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recruiting
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Active, not recruiting
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recruiting
Active, not recruiting
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Active, not recruiting
Active, not recruiting
Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
Active, not recruiting
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer3 recruiting
- Ovarian cancer3 recruiting
- Prostate cancer3 recruiting
- Cervical cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Terminated
Terminated
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026